Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Cancer remains one of the main causes of morbidity and mortality worldwide. Although many pharmacological and clinical advances have been made, there is a constant need for new molecules to improve the overall options for treatment. Natural compounds from animal, microbial, vegetal, or fungal origin represent countless sources of new compounds that can be used as anticancer drugs, provided their activity, bioavailability, and toxicity are adequate. This book aims to compile both original articles and reviews that cover the most recent advances in the use of natural compounds for cancer treatment, and provide new objectives and advice for future research in the field of biological activity of natural compounds.

microbiota --- treatment --- n/a --- sulforaphane --- synergy --- epigenetic --- natural compound --- xenohormesis --- anticancer --- miR-663 --- tyrosine kinase inhibitors --- acetylation --- epidemiology --- double-blinded --- inflammation --- bladder cancer --- polypharmacology --- animal model --- synbiotics --- resveratrol --- royal jelly --- 5-aza-2’-deoxycytine --- saponins --- phenolics --- cardiovascular disease --- antioxidant --- colorectal cancer --- trypsin inhibitors --- seeds --- green tea --- Gac --- randomized clinical trial --- melanoma --- adverse events --- extraction --- microbiome --- Momordica cochinchinensis --- freeze dried extract --- renal cell carcinoma --- methylation --- cancer --- probiotics --- 5-aza-2'-deoxycytine

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue entitled “β-glucan in foods and health benefits” reports on the health benefits of indigestible carbohydrates with respect to metabolic diseases and immune functions. The effects of β-glucan have been investigated through the use isolated preparations or natural dietary fibers from whole grain cereals and brans, yeasts, or Euglena. This Special Issue includes original research articles that are based on human intervention studies that address the effects of β-glucan on metabolic diseases and immune function-related markers as well as in vitro and in vivo studies. It also reviews the health benefits of β-glucans in humans.

Research & information: general --- Biology, life sciences --- Food & society --- humans --- oat β-glucan --- acute glycemic response --- dietary fiber --- preload --- carbohydrates --- β-1,3-glucan --- Euglena gracilis --- Ca2+ signaling --- intestinal epithelial cell --- intravital imaging --- small intestine --- immune system --- barley --- β-glucan --- microarray --- short chain fatty acids --- lipid metabolism. --- low molecular weight --- fermentation --- prebiotics --- Autreobasidium pullulans --- β-1,3-1,6-glucan --- physiological function --- oat beta-glucan --- colitis --- Crohn’s disease --- apoptosis --- autophagy --- TLRs --- Dectin-1 --- rats --- L cell --- glucagon-like peptide 1 (GLP-1) --- glucose tolerance --- short-chain fatty acids --- sIgA --- microbiota --- randomized clinical trial --- symptoms --- gastrointestinal tract --- musculo-skeletal system --- oats --- oatmeal --- beta-glucan --- beta glucan --- health claim --- regulation --- food-health relationship --- gastritis --- inflammatory process --- antioxidant properties --- paramylon --- abdominal fat --- DNA microarray --- gene ontology --- PPAR signaling --- n/a --- Crohn's disease

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue entitled “β-glucan in foods and health benefits” reports on the health benefits of indigestible carbohydrates with respect to metabolic diseases and immune functions. The effects of β-glucan have been investigated through the use isolated preparations or natural dietary fibers from whole grain cereals and brans, yeasts, or Euglena. This Special Issue includes original research articles that are based on human intervention studies that address the effects of β-glucan on metabolic diseases and immune function-related markers as well as in vitro and in vivo studies. It also reviews the health benefits of β-glucans in humans.

humans --- oat β-glucan --- acute glycemic response --- dietary fiber --- preload --- carbohydrates --- β-1,3-glucan --- Euglena gracilis --- Ca2+ signaling --- intestinal epithelial cell --- intravital imaging --- small intestine --- immune system --- barley --- β-glucan --- microarray --- short chain fatty acids --- lipid metabolism. --- low molecular weight --- fermentation --- prebiotics --- Autreobasidium pullulans --- β-1,3-1,6-glucan --- physiological function --- oat beta-glucan --- colitis --- Crohn’s disease --- apoptosis --- autophagy --- TLRs --- Dectin-1 --- rats --- L cell --- glucagon-like peptide 1 (GLP-1) --- glucose tolerance --- short-chain fatty acids --- sIgA --- microbiota --- randomized clinical trial --- symptoms --- gastrointestinal tract --- musculo-skeletal system --- oats --- oatmeal --- beta-glucan --- beta glucan --- health claim --- regulation --- food-health relationship --- gastritis --- inflammatory process --- antioxidant properties --- paramylon --- abdominal fat --- DNA microarray --- gene ontology --- PPAR signaling --- n/a --- Crohn's disease